The molecular mechanism underlying MSC-mediated radiosensitivity in STING-deficient CRC cells may be to overcome defective cGAS/STING-mediated antitumor immunity and TRAIL-dependent cell death. The gene discussed is STING1; the disease is colorectal carcinoma.